Compare CDNL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDNL | AORT |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2025 | 1996 |
| Metric | CDNL | AORT |
|---|---|---|
| Price | $39.23 | $28.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $38.00 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 705.1K | 663.1K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $456,045,369.00 | $298,836,000.00 |
| Revenue This Year | $50.30 | $14.20 |
| Revenue Next Year | $8.41 | $11.20 |
| P/E Ratio | $74.38 | ★ N/A |
| Revenue Growth | ★ 44.69 | 18.01 |
| 52 Week Low | $21.98 | $19.16 |
| 52 Week High | $96.40 | $48.25 |
| Indicator | CDNL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 29.83 | 62.19 |
| Support Level | $24.46 | $25.79 |
| Resistance Level | $65.55 | $38.02 |
| Average True Range (ATR) | 4.77 | 1.19 |
| MACD | -2.64 | 0.12 |
| Stochastic Oscillator | 13.99 | 79.00 |
Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. The company provides wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. It derives all revenue in the United States of America from construction projects based in North Carolina and South Carolina.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.